文献速递心血管MR

心脏磁共振临床试验的未来

The Future of Cardiac Magnetic Resonance Clinical Trials.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-12-15

论文阐述心脏磁共振(CMR)在冠状动脉疾病、心肌病、先天性心脏病、心脏肿瘤学及瓣膜/血管病等心血管诊疗中的核心作用。指出CMR可在一次成像中提供解剖、生理与功能数据,有助于缩小样本量并提供机制数据,从而改进临床试验设计;基于CMR的影像引导策略可能提升心血管诊疗路径的安全性、有效性与成本效益。文中还讨论CMR融入临床试验的优势、局限与挑战,并对试验研究者提出建议,列举评估CMR影像引导路径有效性的著名试验。

要点

  • CMR可在一次成像中同步提供解剖、生理与功能数据,有助于改进临床试验设计。
  • CMR的广泛应用、安全性与综合成像能力可缩小临床试验样本量并提供机制数据。
  • 基于CMR的前瞻性影像引导策略可能提升心血管诊疗路径的安全性、有效性与成本效益。

核心结论

  • 随着大规模临床试验设计向整合个体化医疗、成本效益与新型疗法机制洞察演变,CMR的整合将继续发挥关键作用。

研究设计与样本

  • 本文为论述性文献,未报告系统检索范围、纳入文献数量或证据分级方法。

临床应用与阅片要点

  • 作者指出,CMR的广泛应用、安全性与一次成像获取解剖、生理及功能数据的能力,可通过缩小样本量和提供机制数据来改进临床试验设计与实施。
  • 作者指出,基于CMR的前瞻性影像引导策略可能提升全球临床实践中心血管诊疗路径的安全性、有效性与成本效益。
  • 文中将讨论CMR融入未来临床试验设计与实施的优势、局限与挑战,并对试验研究者提出建议。

局限性

  • 原文提及将涵盖CMR融入未来临床试验设计与实施的优势、局限与挑战,但摘要未逐条列出具体局限内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Over the past 2 decades, cardiac magnetic resonance (CMR) has become an essential component of cardiovascular clinical care and contributed to imaging-guided diagnosis and management of coronary artery disease, cardiomyopathy, congenital heart disease, cardio-oncology, valvular, and vascular disease, amongst others. The widespread availability, safety, and capability of CMR to provide corresponding anatomical, physiological, and functional data in 1 imaging session can improve the design and conduct of clinical trials through both a reduction of sample size and provision of important mechanistic data that may augment clinical trial findings. Moreover, prospective imaging-guided strategies using CMR can enhance safety, efficacy, and cost-effectiveness of cardiovascular pathways in clinical practice around the world. As the future of large-scale clinical trial design evolves to integrate personalized medicine, cost-effectiveness, and mechanistic insights of novel therapies, the integration of CMR will continue to play a critical role. In this document, the attributes, limitations, and challenges of CMR's integration into the future design and conduct of clinical trials will also be covered, and recommendations for trialists will be explored. Several prominent examples of clinical trials that test the efficacy of CMR-imaging guided pathways will also be discussed.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Rabbat, Kwong, Heitner, et al. The Future of Cardiac Magnetic Resonance Clinical Trials. JACC Cardiovasc Imaging. 2021. PMID: 34922874. doi:10.1016/j.jcmg.2021.07.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。